Revumenib
HO177
Phase 3 small_molecule active
Quick answer
Revumenib for Acute Myeloid Leukemia, Adult is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Acute Myeloid Leukemia, Adult
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active